Laser Photocoagulation for Retinal Conditions

Focal laser treatment is directed at small, specific areas of the retina. A retina specialist uses this approach to close individual leaking blood vessels or treat localized clusters of abnormal vessels. It is most commonly used for diabetic macular edema, where vessels near the macula are leaking fluid and causing swelling that blurs central vision.

Because this approach involves only a limited number of laser spots in a precise area, it typically produces fewer side effects than broader treatments. The goal is to stop leakage at its source while preserving as much healthy surrounding tissue as possible.

Pan-retinal photocoagulation, also called scatter laser treatment or PRP, covers a much larger portion of the retina. During PRP, hundreds of laser burns are placed across the peripheral retina, meaning the outer regions, while carefully avoiding the central macula. This is the established treatment for proliferative diabetic retinopathy.

When parts of the retina are deprived of adequate blood flow due to diabetes, they release chemical signals that stimulate the growth of new, unstable blood vessels. These abnormal vessels are prone to bleeding and can cause severe vision loss. PRP works by treating the oxygen-deprived tissue and quieting those growth signals. Research has consistently shown that PRP significantly lowers the risk of severe vision loss from proliferative diabetic retinopathy.

When a retinal tear is detected, laser photocoagulation can be used to build a ring of scar tissue around it. This ring acts like a spot-weld, bonding the retina firmly to the tissue beneath it and preventing fluid from passing through the tear. Without this seal, fluid can seep under the retina and lift it away from the eye wall, causing a retinal detachment.

Treating a retinal tear early with barrier laser is one of the most effective preventive steps available in retinal care. It is far less invasive and has a much higher success rate than repairing a full detachment after it has already occurred.

Improvements in laser technology have made treatment more precise and more comfortable for patients. Pattern scanning laser photocoagulation, known as PASCAL, delivers pulses that are far shorter than those used in traditional single-spot laser systems. These shorter pulses require less total energy, which means less heat spreads into nearby tissue. The result is smaller, more uniform treatment spots, less damage to the inner retina, reduced pain during treatment, and a smoother recovery.

Targeted retinal photocoagulation (TRP) is an emerging approach that uses detailed imaging to identify the specific areas of the retina with poor blood flow. The laser is then applied precisely to those regions rather than the full peripheral retina. This may reduce the total number of burns needed and lower the risk of side effects associated with traditional PRP.

Some degree of side effects after laser photocoagulation is a normal part of the healing process. Patients most commonly notice the following:

• Blurred vision for one to two days after treatment
• Mild soreness or a dull ache in or around the treated eye
• Increased sensitivity to light for several hours
• Small areas of reduced sensitivity in the treated regions, which are often not noticeable during everyday activities

These effects typically resolve on their own within a few days. Contact our office if anything seems unusually severe or does not improve as expected.

Because PRP treats a large area of the outer retina, it can lead to more noticeable visual changes in some patients. These may include a mild reduction in central vision sharpness, decreased night vision, reduced color perception, or lower contrast sensitivity. Some narrowing of the peripheral (side) field of vision is also possible, since the laser intentionally creates areas of scar tissue across the peripheral retina.

While these changes can feel unsettling, they are generally mild compared to the severe central vision loss that untreated proliferative diabetic retinopathy can cause over time. The intent of PRP is to protect the central vision needed for reading, driving, and recognizing faces by accepting some reduction in peripheral function in exchange for stopping the disease from advancing further.

Serious complications from laser photocoagulation are uncommon but can occur. They include bleeding inside the eye, known as a vitreous hemorrhage, traction on the retina caused by scar tissue contracting after treatment, and an accidental burn to the fovea, which is the tiny central pit of the macula responsible for the sharpest vision. A foveal burn can result in meaningful permanent vision loss. Other rare complications include choroidal detachment and a sudden rise in eye pressure called acute angle-closure glaucoma.

Our retina specialists use careful targeting, appropriate energy settings, and advanced imaging to minimize these risks at every step. For most patients, the benefit of preventing serious disease progression clearly outweighs the small risk of these uncommon complications.

The experience varies from person to person. Numbing drops are applied before the procedure, which reduces most discomfort, but they do not eliminate all sensation. If you are facing pan-retinal photocoagulation after having focal laser treatment, it is worth knowing that PRP involves significantly more laser spots and tends to produce more sensation, particularly toward the end of a session when the peripheral retina is being treated in greater detail. The newer PASCAL technology uses shorter pulses and lower energy, which clinical experience suggests is more comfortable than traditional single-spot laser for many patients. If discomfort is a concern, let your retina specialist know before the procedure begins so that your options can be discussed in advance.

The laser application itself typically takes 10 to 30 minutes, but the complete appointment usually runs one to two hours once preparation and dilation time are included. For conditions requiring a large number of laser spots, such as proliferative diabetic retinopathy, we often divide treatment across two or three sessions rather than completing everything in one visit. Spreading the treatment out limits the burden on the retina at any one time and tends to make the overall experience more manageable for patients.

Laser photocoagulation is primarily a disease-stabilizing treatment, not a restorative one. Its main purpose is to stop or slow the progression of retinal damage and protect the vision you currently have, not to reverse damage that has already occurred. That said, some patients with macular edema do experience modest improvements in central vision after laser reduces the swelling, but this outcome is not guaranteed and depends on how long the swelling has been present and whether the underlying retinal tissue has been permanently affected. In general, the earlier treatment is started, the greater the chance of preserving functional vision.

The scar tissue created by laser is permanent, and a properly sealed retinal tear generally stays sealed at that location. However, new tears can form in other areas of the retina over time, particularly in people with high myopia or other structural risk factors. For diabetic retinopathy, the underlying disease process continues for as long as diabetes remains present, and new abnormal vessels can develop even after a successful course of PRP. This is why controlling blood sugar, blood pressure, and cholesterol, and maintaining all scheduled follow-up appointments, remain important even after laser treatment has achieved a good initial result. Laser addresses the retinal consequences of these diseases but does not treat the diseases themselves.

For several conditions, yes. Anti-VEGF injections have become the primary first-line treatment for diabetic macular edema and are also used for proliferative diabetic retinopathy in some patients. For retinal tears, cryopexy, a freezing treatment that creates a similar protective ring of scar tissue around a tear, is a well-established alternative when laser is not the most practical option. Whether laser, injections, cryopexy, or a combination of approaches is most appropriate depends on your specific condition, how far it has progressed, and a number of individual factors. Your retina specialist will recommend the approach that offers the best balance of effectiveness and tolerability for your situation.

Some temporary blurring and mild visual changes in the first day or two after laser photocoagulation are expected and generally resolve on their own. However, if you notice a sudden or significant drop in vision, a new increase in floaters, new flashes of light, or a curtain or shadow appearing in your visual field at any point after treatment, you should contact us right away rather than waiting for your next scheduled appointment. These symptoms could indicate a complication that requires prompt evaluation. We are committed to seeing existing patients as quickly as possible when something concerning arises.